Cioffi Camille C, Kosty Derek, Nachbar Sarah, Capron Christopher G, Mauricio Anne Marie, Tavalire Hannah F
University of Oregon, Eugene, OR, United States.
Drug Alcohol Depend Rep. 2022 Jun;3:100046. doi: 10.1016/j.dadr.2022.100046. Epub 2022 Mar 24.
People who inject drugs (PWID) are at greater risk for severe morbidity and mortality associated with COVID-19 due to comorbid, chronic, medical conditions and structural inequities associated with housing instability and incarceration. As such, they are a population that would greatly benefit from COVID-19 vaccination.
We surveyed 350 syringe exchange clients between March 2021 and June 2021 to collect information on vaccine uptake among PWID, facilitators and barriers to vaccination, and demographic correlates of vaccine hesitancy.
Findings highlight that among PWID, vaccination access was remarkably low with only 10% of the sample receiving a COVID-19 vaccine. Vaccine acceptability among people who were vaccinated was 42% highlighting barriers to access. Motivation for vaccination included a desire to keep family members and other community members safe and a desire to feel safe around other people. Barriers to vaccination included concerns about vaccine side effects, lack of concern surrounding the effects of COVID-19, and insufficient information about how the vaccine works, along with general distrust of the vaccine development and deployment process.
There is a need for structural interventions and individual behavioral interventions to improve COVID-19 vaccine access and uptake among PWID. Limitations and implications for next steps and future directions are discussed.
由于合并存在的慢性疾病以及与住房不稳定和监禁相关的结构性不平等,注射毒品者(PWID)感染新冠病毒(COVID-19)后出现严重发病和死亡的风险更高。因此,他们是能从COVID-19疫苗接种中大幅受益的人群。
我们在2021年3月至2021年6月期间对350名注射器交换项目客户进行了调查,以收集有关PWID疫苗接种情况、接种的促进因素和障碍以及疫苗犹豫的人口统计学相关因素的信息。
研究结果表明,在PWID中,疫苗接种率极低,只有10%的样本接种了COVID-19疫苗。接种者中的疫苗可接受率为42%,凸显了接种障碍。接种疫苗的动机包括希望保护家庭成员和其他社区成员安全,以及希望在他人身边时感到安全。接种疫苗的障碍包括对疫苗副作用的担忧、对COVID-19影响缺乏关注、对疫苗作用方式的信息不足,以及对疫苗研发和部署过程的普遍不信任。
需要采取结构性干预措施和个体行为干预措施,以改善PWID获得和接种COVID-19疫苗的情况。讨论了局限性以及对下一步和未来方向的影响。